These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3911481)

  • 21. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic side effects of the platelet-inhibitory drug ticlopidine.
    Berglund U; Wallentin L
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():281-3. PubMed ID: 3159214
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence on platelet function by heparin in men with unstable coronary artery disease.
    Berglund U; Wallentin L
    Thromb Haemost; 1991 Dec; 66(6):648-51. PubMed ID: 1796408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
    J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ticlopidine on platelet function and blood coagulation.
    Violi F; Alessandri C; Frattaroli S; Ghiselli A; Balsano F
    Thromb Haemost; 1982 Oct; 48(2):166-8. PubMed ID: 6217577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet reactivity to "in vitro" allergen challenge in asthmatic patients.
    de Sousa JR; Santos MC; Carlos ML; Carlos AG
    Allergol Immunopathol (Madr); 1992; 20(1):13-6. PubMed ID: 1387285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperaggregability of platelets in thromboembolic disorders.
    Yamazaki H; Takahashi T; Sano T
    Thromb Diath Haemorrh; 1975 Sep; 34(1):94-105. PubMed ID: 242093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombocyte function in unstable angina pectoris].
    Terres W; Hamm CW; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1988 Jul; 113(30):1182-6. PubMed ID: 2840254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of ticlopidine on platelet function as assessed by three different methods.
    Cuyun-Lira O; Kaneko M; Takafuta T; Satoh K; Ohnishi M; Yatomi Y; Ozaki Y
    Eur J Pharm Sci; 2007 Jan; 30(1):21-5. PubMed ID: 17070023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.
    Weltermann A; Fritsch P; Kyrle PA; Schoenauer V; Heinze G; Wojta J; Christ G; Huber K
    Thromb Res; 2003; 112(1-2):19-24. PubMed ID: 15013268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.